Scholars Central

Conference abstractPublished 5 Mar 2018

Developing site-specifi cally modifi ed ADCs using a chemoenzymatic approach

Authors: David Rabuka

Catalent Biologics, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We have developed the SMARTagTM technology platform, which enables precise, programmable, site-selective chemical protein modifi cation. Leveraging the target sequence of formylglycine generating enzyme (FGE), we chemoenzymatically modify proteins to generate a precisely placed aldehyde functionality that can be chemically elaborated. Subsequently, novel ligation chemistry is employed that exploits this “aldehyde tag” site. We will present recent data on our novel protein modifi cation platform and its application to generating novel bioconjugates, including ADCs, utilizing our new conjugation chemistries and linkers. Th e application of these chemistries to generate site-specifi cally modifi ed bioconjugates with improved effi cacy and safety profi les will be presented. Additionally, we will highlight the progress in developing conjugates with a focus on preclinical studies as well as highlight our progress in cell line development and manufacturing by using this chemoenzymatic approach.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels